Hyperglycaemia after Bedinvetmab (Librela) in dogs

The FDA has received 143 reports of hyperglycaemia in dogs after Bedinvetmab. That is 0.7% of all reports for this medicine, compared with 0.5% across reports for all dog medicines.

143Reports

86%Marked serious

2.8%Recovered

32%Died or euthanised

11 daysTypical onset

How soon it started

Same day

15 12%

1–2 days

18 15%

3–7 days

22 18%

1–4 weeks

37 30%

Over a month

30 25%

How the animals did

Recovered

3 2.1%

Recovered with lasting effects

1 0.7%

Still unwell when reported

88 62%

Died

15 10%

Euthanised

31 22%

Not known

5 3.5%

Problems reported at the same time

78 55%

49 34%

46 32%

44 31%

43 30%

42 29%

36 25%

34 24%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Bedinvetmab reduces osteoarthritis pain in dogs (monthly injection).

Products with this ingredient include Librela. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Bedinvetmab cause hyperglycaemia in dogs?: 143 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 11 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Hyperglycaemia with similar medicines

Hyperglycaemia after Lokivetmab (Cytopoint) 71 reports · 1.1% of its reports

All reported side effects of Bedinvetmab in dogs · Medicines most reported with hyperglycaemia